We are live on ! Find out more
OM icon

Outset Medical
OM

73 hedge funds and large institutions have $23.4M invested in Outset Medical in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more call options, than puts

Call options by funds: $159K | Put options by funds: $73K

33% more capital invested

Capital invested by funds: $17.6M → $23.4M (+$5.75M)

0.66% less ownership

Funds ownership: 3.33% → 2.67% (-0.66%)

6% less funds holding

Funds holding: 78 → 73 (-5)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

33% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 24

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
16
Reduced
24
Closed
16
Calls
$159K
Puts
$73K
Net Calls
+$86K
Net Calls Change
+$85K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$526K
2
BC
Birchview Capital
Vermont
+$299K
3
Morgan Stanley
Morgan Stanley
New York
+$210K
4
Squarepoint
Squarepoint
New York
+$130K
5
Two Sigma Investments
Two Sigma Investments
New York
+$108K

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$1.23M
2
MIC
Mubadala Investment Company
United Arab Emirates
-$975K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$917K
4
Millennium Management
Millennium Management
New York
-$412K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$290K
Name Holding Trade Value Shares
Change 		Change in
Stake
RS
51
R Squared
Hong Kong
$11K +$8.24K +660 New
CWM
52
Centricity Wealth Management
Ohio
$9.39K +$7.04K +564 New
JP Morgan Chase
53
JP Morgan Chase
New York
$6.29K -$8.52K -683 -64%
Bank of America
54
Bank of America
North Carolina
$6.09K -$12K -959 -72%
RMP
55
Richards, Merrill & Peterson
Washington
$3.33K +$2.5K +200 New
Citadel Advisors
56
Citadel Advisors
Florida
$3.24K – – –
SIA
57
Sit Investment Associates
Minnesota
$3K – – –
Osaic Holdings
58
Osaic Holdings
Arizona
$2.35K – – –
Federated Hermes
59
Federated Hermes
Pennsylvania
$1.63K -$325 -26 -21%
Citigroup
60
Citigroup
New York
$1.54K +$974 +78 +520%
Kayne Anderson Rudnick Investment Management
61
Kayne Anderson Rudnick Investment Management
California
$1.11K – – –
SS
62
SBI Securities
Japan
$1.06K +$799 +64 New
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$1K +$761 +61 +185%
Carson Wealth (CWM LLC)
64
Carson Wealth (CWM LLC)
Nebraska
$1K +$836 +67 New
FDW
65
Fourth Dimension Wealth
Ohio
$638 +$474 +38 New
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$515 +$387 +31 New
ATC
67
Adirondack Trust Company
New York
$308 – – –
Barclays
68
Barclays
United Kingdom
$71 – – –
Northwestern Mutual Wealth Management
69
Northwestern Mutual Wealth Management
Wisconsin
$67 +$50 +4 New
PNC Financial Services Group
70
PNC Financial Services Group
Pennsylvania
$48 – – –
US Bancorp
71
US Bancorp
Minnesota
$42 -$4.32K -346 -99%
IA
72
IFP Advisors
Florida
$38 – – –
MTIC
73
Missouri Trust & Investment Company
Missouri
$26 – – –
CWM
74
Cranbrook Wealth Management
Michigan
$7 – – –
Ameriprise
75
Ameriprise
Minnesota
– -$1.23M -120,682 Closed
1 2
3
4

OM Hedge Fund Activity: Q4 2024 in Review

73 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2024, worth a combined $23.4M — up 33% from $17.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OM and 12 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 16 added.

The largest buyer was Renaissance Technologies, adding an estimated $526K. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.

  • 73 institutional investors held Outset Medical (OM) as of Q4 2024, down from 78 in Q3 2024.
  • Funds reported $23.4M of Outset Medical stock for Q4 2024, up 33% quarter-over-quarter.
  • 12 funds opened new Outset Medical positions in Q4 2024 and 16 closed out, a net change of -4 holders.
  • The largest Outset Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $526K added.
  • The largest Outset Medical seller in Q4 2024 was Ameriprise, an estimated $1.23M sold.

Based on aggregated 13F filings for Q4 2024.